SJOGRENS DISEASE
Clinical trials for SJOGRENS DISEASE explained in plain language.
Never miss a new study
Get alerted when new SJOGRENS DISEASE trials appear
Sign up with your email to follow new studies for SJOGRENS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug targets autoimmune diseases in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called OM336 in 39 adults with active Sjogren's disease or idiopathic inflammatory myopathy who have not improved with at least two prior treatments. OM336 is an engineered antibody designed to target and potentially reduce harmful immune c…
Matched conditions: SJOGRENS DISEASE
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New immune cell combo tackles tough autoimmune diseases
Disease control Recruiting nowThis phase 2 trial tests a therapy called AlloNK, made from donor cord blood immune cells, combined with the drug rituximab. It aims to see if this combination is safe and can help people with severe forms of rheumatoid arthritis, Sjögren's disease, myositis, or scleroderma that …
Matched conditions: SJOGRENS DISEASE
Phase: PHASE2 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC